The COVID-19 Pandemic and the Future of Telemedicine

The use of telemedicine was quite limited in most OECD countries before the COVID-19 pandemic, held back by regulatory barriers and hesitancy from patients and providers. In early 2020, as COVID-19 massively disrupted in-person care, governments moved quickly to promote the use of telemedicine. The...

Full description

Bibliographic Details
Corporate Author: Organisation for Economic Co-operation and Development
Format: eBook
Language:English
Published: Paris OECD Publishing 2023
Series:OECD Health Policy Studies
Subjects:
Online Access:
Collection: OECD Books and Papers - Collection details see MPG.ReNa
LEADER 02560nmm a2200289 u 4500
001 EB002155059
003 EBX01000000000000001293185
005 00000000000000.0
007 cr|||||||||||||||||||||
008 230405 ||| eng
020 |a 9789264758155 
020 |a 9789264484566 
020 |a 9789264420038 
245 0 0 |a The COVID-19 Pandemic and the Future of Telemedicine  |h Elektronische Ressource  |c Organisation for Economic Co-operation and Development 
260 |a Paris  |b OECD Publishing  |c 2023 
300 |a 180 p.  |c 21 x 28cm 
505 0 |a Country participation in data collection -- Use of telemedicine has boomed during the COVID‑19 pandemic -- -- Policy priorities for promoting the best use of telemedicine -- Supplementary results from the OECD Survey on Telemedicine and COVID‑19, 2021‑22 -- Overview tables of the literature review -- Foreword -- The regulation and financing of telemedicine in the OECD, before and during COVID‑19 -- Executive summary -- The impact of telemedicine on health care system performance -- Systematic review of the literature 
653 |a Social Issues/Migration/Health 
710 2 |a Organisation for Economic Co-operation and Development 
041 0 7 |a eng  |2 ISO 639-2 
989 |b OECD  |a OECD Books and Papers 
490 0 |a OECD Health Policy Studies 
028 5 0 |a 10.1787/ac8b0a27-en 
856 4 0 |a oecd-ilibrary.org  |u https://doi.org/10.1787/ac8b0a27-en  |x Verlag  |3 Volltext 
082 0 |a 304 
082 0 |a 610 
520 |a The use of telemedicine was quite limited in most OECD countries before the COVID-19 pandemic, held back by regulatory barriers and hesitancy from patients and providers. In early 2020, as COVID-19 massively disrupted in-person care, governments moved quickly to promote the use of telemedicine. The number of teleconsultations skyrocketed, playing a vital role in maintaining access to care, but only partly offsetting reductions in in-person care. This report provides an overview of the use of telemedicine in OECD countries, describing how governments scaled up remote care during the pandemic and exploring the impact that this massive shift to remote care has had on health care system performance. Telemedicine may be here to stay, but questions remain concerning how to regulate its use, how to pay for it, how to integrate it with in-person care, and how to make sure that it constitutes good value for money for all. This report puts forth priorities for policy makers to inform the discussion and to promote the best use of remote care services in the future